Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5093511
Max Phase: Preclinical
Molecular Formula: C33H36N4O2
Molecular Weight: 520.68
Molecule Type: Unknown
Associated Items:
ID: ALA5093511
Max Phase: Preclinical
Molecular Formula: C33H36N4O2
Molecular Weight: 520.68
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C#CC[C@H](NCc1ccc(-c2ccccc2)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC(C)(C)C
Standard InChI: InChI=1S/C33H36N4O2/c1-5-11-29(34-21-23-16-18-25(19-17-23)24-12-7-6-8-13-24)31(38)36-30(32(39)37-33(2,3)4)20-26-22-35-28-15-10-9-14-27(26)28/h1,6-10,12-19,22,29-30,34-35H,11,20-21H2,2-4H3,(H,36,38)(H,37,39)/t29-,30-/m0/s1
Standard InChI Key: QEVQDSOXNYAYCN-KYJUHHDHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 520.68 | Molecular Weight (Monoisotopic): 520.2838 | AlogP: 4.96 | #Rotatable Bonds: 10 |
Polar Surface Area: 86.02 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.73 | CX Basic pKa: 7.36 | CX LogP: 5.07 | CX LogD: 4.79 |
Aromatic Rings: 4 | Heavy Atoms: 39 | QED Weighted: 0.22 | Np Likeness Score: -0.53 |
1. Di Sarno V, Lauro G, Musella S, Ciaglia T, Vestuto V, Sala M, Scala MC, Smaldone G, Di Matteo F, Novi S, Tecce MF, Moltedo O, Bifulco G, Campiglia P, Gomez-Monterrey IM, Snoeck R, Andrei G, Ostacolo C, Bertamino A.. (2021) Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization., 226 [PMID:34571172] [10.1016/j.ejmech.2021.113863] |
Source(1):